Clinicopathological Features and Type of Surgery for Lynch Syndrome: Changes during the Past Two Decades
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose The Korean Hereditary Tumor Registry, the first and one of the largest registries of hereditary tumors in Korea, has registered about 500 families with hereditary cancer syndromes. This study evaluates the temporal changes in clinicopathologic features and surgical patterns of Lynch syndrome (LS) patients. Materials and Methods Data on 182 unrelated LS patients were collected retrospectively. The patients were divided into the period 1 group (registered in 1990-2004) and 2 (registered in 2005-2014). The clinical characteristics of the two groups were compared to identify changes over time. Results The period 1 group included 76 patients; the period 2 group, 106 patients. The mean ages at diagnosis were 45.1 years (range, 13 to 85 years) for group 1 and 49.7 years (range, 20 to 84 years) for group 2 (p=0.015). The TNM stage at diagnosis did not differ significantly— period 1 group: stage 0-I (n=18, 23.7%), II (n=37, 48.7%), III (n=19, 25.0%), and IV (n=2, 2.6%); period 2 group: stage 0-I (n=30, 28.3%), II (n=35, 33.0%), III (n=37, 34.9%), and IV (n=4, 3.8%). Extended resection was more frequently performed (55/76, 72.4%) in the period 1 group than period 2 (49/106, 46.2%) (p=0.001). Conclusion Colorectal cancer in patients with LS registered at the Korean Hereditary Tumor Registry is still diagnosed at an advanced stage, more than two decades after registry’s establishment. Segmental resection was more frequently performed in the past decade. A prompt nationwide effort to raise public awareness of hereditary colorectal cancer and to support hereditary cancer registries is required in Korea.
Abstract
Purpose The Korean Hereditary Tumor Registry, the first and one of the largest registries of hereditary tumors in Korea, has registered about 500 families with hereditary cancer syndromes. This study evaluates the temporal changes in clinicopathologic features and surgical patterns of Lynch syndrome (LS) patients. Materials and Methods Data on 182 unrelated LS patients were collected retrospectively. The patients were divided into the period 1 group (registered in 1990-2004) and 2 (registered in 2005-2014). The clinical characteristics of the two groups were compared to identify changes over time. Results The period 1 group included 76 patients; the period 2 group, 106 patients. The mean ages at diagnosis were 45.1 years (range, 13 to 85 years) for group 1 and 49.7 years (range, 20 to 84 years) for group 2 (p=0.015). The TNM stage at diagnosis did not differ significantly— period 1 group: stage 0-I (n=18, 23.7%), II (n=37, 48.7%), III (n=19, 25.0%), and IV (n=2, 2.6%); period 2 group: stage 0-I (n=30, 28.3%), II (n=35, 33.0%), III (n=37, 34.9%), and IV (n=4, 3.8%). Extended resection was more frequently performed (55/76, 72.4%) in the period 1 group than period 2 (49/106, 46.2%) (p=0.001). Conclusion Colorectal cancer in patients with LS registered at the Korean Hereditary Tumor Registry is still diagnosed at an advanced stage, more than two decades after registry’s establishment. Segmental resection was more frequently performed in the past decade. A prompt nationwide effort to raise public awareness of hereditary colorectal cancer and to support hereditary cancer registries is required in Korea.
참고문헌 (24)
- Aaltonen LA, "Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease", N Engl J Med, 338, pp.1481~1487 (1998)
- Vasen HF, "Guidelines for the clinical management of Lynch syndrome(hereditary non-polyposis cancer)", J Med Genet, 44, pp.353~362 (2007)
- Lynch HT, "Hereditary colorectal cancer", N Engl J Med, 348, pp.919~932 (2003)
- Vasen HF, "New clinical criteria for hereditary nonpolyposis colorectal cancer(HNPCC, Lynch syndrome)proposed by the International Collaborative group on HNPCC", Gastroenterology, 116, pp.1453~1456 (1999)
- Umar A, "Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer(Lynch syndrome)and microsatellite instability", J Natl Cancer Inst, 96, pp.261~268 (2004)
- Rodriguez-Bigas MA, "Hereditary colorectal cancer", pp.535~544 (2010), Springe
- Barrow E, "Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations", Clin Genet, 74, pp.233~242 (2008)
- de Vos tot Nederveen Cappel WH, "Colorectal surveillance in Lynch syndrome families", Fam Cancer, 12, pp.261~265 (2013)
- Schofield L, "Population-based screening for Lynch syndrome in Western Australia", Int J Cancer, 135, pp.1085~1091 (2014)
- Sturgeon D, "Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry", Dis Colon Rectum, 56, pp.308~314 (2013)
- Barrow P, "Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome", Br J Surg, 100, pp.1719~1731 (2013)
- Mallinson EK, "The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis", Gut, 59, pp.1378~1382 (2010)
- Park JG, "Suspected HNPCC and Amsterdam criteria II : evaluation of mutation detection rate, an international collaborative study", Int J Colorectal Dis, 17, pp.109~114 (2002)
- Edge SB, "AJCC cancer staging manual" (2010), Springer-Verlag
- Barrison AF, "Colorectal cancer screening and familial risk : a survey of internal medicine residents' knowledge and practice patterns", Am J Gastroenterol, 98, pp.1410~1416 (2003)
- 박장호, "Knowledge of and Practice Patterns for Hereditary Colorectal Cancer Syndromes in Korean Surgical Residents", Annals of Coloproctolgy, 29(5), pp.186~191 (2013), 대한대장항문학회
- Brixen LM, "Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study", Colorectal Dis, 15, pp.816~823 (2013)
- de Jong AE, "Decrease in mortality in Lynch syndrome families because of surveillance", Gastroenterology, 130, pp.665~671 (2006)
- Vasen HF, "Hereditary nonpolyposis colorectal cancer : results of long-term surveillance in 50 families", Eur J Cancer, 31A, pp.1145~1148 (1995)
- Cairns SR, "Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups(update from 2002)", Gut, 59, pp.666~689 (2010)
- Syngal S, "ACG clinical guideline : Genetic testing and management of hereditary gastrointestinal cancer syndromes", Am J Gastroenterol, 110, pp.223~262 (2015)
- Win AK, "Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers", Ann Surg Oncol, 20, pp.1829~1836 (2013)
- Rodriguez-Bigas MA, "Surgical treatment of hereditary nonpolyposis colorectal cancer(HNPCC, Lynch syndrome)", Fam Cancer, 12, pp.295~300 (2013)
- Haanstra JF, "Quality of life after surgery for colon cancer in patients with Lynch syndrome : partial versus subtotal colectomy", Dis Colon Rectum, 55, pp.653~659 (2012)